One-year survival and recovery in elderly COVID-19 patients under scrutiny
NCT ID NCT05184166
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study follows people aged 70 and older who were hospitalized with severe COVID-19 for one year after their diagnosis. Researchers aim to describe how many survive and how well they recover, including physical and mental function. The goal is to better understand the long-term impact of severe COVID-19 in older adults.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could help doctors better predict recovery and plan care for older patients with severe COVID-19.
- What could go wrong
- This is an observational study, not a treatment trial, so it cannot prove what helps or harms. Results may not apply to all elderly patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Du Mans
Le Mans, 72000, France
-
Chu Angers
Angers, 49000, France
-
Chu Rennes
Rennes, 35000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?